
Mankind Pharma Sees Sharp Open Interest Surge Amid Strong Derivatives Activity
2026-09-21 14:00:08Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by rising volumes and sustained investor participation, reflecting renewed confidence in the mid-cap pharmaceutical player.
Read full news article
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Market Momentum
2026-09-21 13:00:07Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by rising volumes and sustained investor participation, reflecting renewed optimism in the mid-cap pharmaceutical player.
Read full news article
Mankind Pharma Ltd Surges 5.17% to Day's High of Rs 2437 — Outperforms Sector by 3.62 Percentage Points
2026-09-21 12:03:24The Sensex advanced 0.77% on 21 Sep 2026, yet Mankind Pharma Ltd outpaced both the benchmark and its sector with a 5.17% intraday gain, reaching a high of Rs 2437. This 3.62 percentage-point outperformance highlights a stock-specific strength amid a broadly positive market environment.
Read full news article
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-09-21 12:00:09Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by rising volumes and sustained investor participation, reflecting renewed confidence in the mid-cap pharmaceutical player.
Read full news article
Mankind Pharma Ltd Sees Sharp Open Interest Surge Amid Bullish Market Momentum
2026-09-21 11:00:10Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector peers with a 4.83% gain today, supported by robust volume and rising investor participation, reflecting renewed optimism among traders and investors.
Read full news article
Mankind Pharma Sees Significant Open Interest Surge Amid Bullish Momentum
2026-09-21 10:00:10Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock has outperformed its sector peers with a 3.29% gain today, supported by rising volumes and sustained investor interest, reflecting a cautious yet optimistic market stance.
Read full news article
Mankind Pharma Ltd is Rated Hold by MarketsMOJO
2026-09-12 10:10:03Mankind Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-09-03 08:05:51Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest daily price increase of 0.85%, recent technical indicators suggest a nuanced outlook for investors, with mixed signals from MACD, RSI, moving averages, and other momentum tools.
Read full news article
Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-09-02 08:09:45Mankind Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the pharmaceutical mid-cap continues to demonstrate resilience with a year-to-date return of 7.45%, outperforming the Sensex’s negative 9.71% over the same period.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Mankind Pharma Ltd has declared 100% dividend, ex-date: 08 Aug 25
No Splits history available
No Bonus history available
No Rights history available






